Stents Market Size & Growth Forecast 2027–2036, By Segments (Product, Material, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Product Segment Analysis: Vascular (Largest Segment) vs Non-vascular Stents (Fastest-Growing Segment)

The vascular stents segment accounted for an 86.04% share of the stents market in 2026, supported by the widespread use of stenting procedures to restore and maintain blood flow in narrowed or obstructed blood vessels. Vascular stents provide structural support to treated vessels following interventional procedures, helping maintain vessel patency and improving the effectiveness of revascularization. Continued demand for minimally invasive treatment approaches, alongside the growing need to manage cardiovascular and peripheral vascular conditions, supports the broad adoption of vascular stents. Ongoing improvements in stent design, deliverability, flexibility, and biocompatibility are also contributing to their use across increasingly complex vascular procedures, reinforcing the segment's established position in the product landscape.

The non-vascular stents segment is expected to register the fastest growth as minimally invasive interventions increasingly expand beyond conventional vascular applications. Non-vascular stents are used to maintain the openness of tubular structures in areas such as the gastrointestinal tract, respiratory system, and biliary pathways, providing an alternative to more invasive surgical interventions in appropriate cases. Improvements in stent flexibility, placement accuracy, and material performance are supporting broader application across different anatomical sites. Increasing demand for procedures that reduce recovery time and hospital burden, together with greater adoption of endoscopic and image-guided interventions, is expected to encourage further use of non-vascular stents.

Material Segment Analysis: Metallic Stents (Largest Segment) vs Non-metallic Stents (Fastest-Growing Segment)

The metallic stents segment represented a 58.75% share of the stents market in 2026, reflecting the established use of metal-based materials for providing reliable mechanical support in treated vessels and other anatomical structures. Metallic stents offer strength, structural stability, and the ability to maintain the desired lumen or passage after deployment, making them suitable for a wide range of interventional procedures. Advances in alloy composition, surface modification, flexibility, and stent architecture have further improved the performance characteristics of metallic devices. Their established clinical use and compatibility with diverse stent designs continue to support demand, particularly in procedures requiring durable structural support.

The non-metallic stents segment is expected to experience the fastest growth, driven by continued interest in materials that can provide improved flexibility, biocompatibility, and application-specific performance. Non-metallic materials can offer design opportunities that differ from conventional metal-based devices, including greater flexibility and the potential to develop stents with specialized degradation or drug-delivery characteristics. Research into advanced polymers and other biomaterials is expanding the range of potential applications for these devices. Growing emphasis on patient-specific treatment approaches and continued innovation in minimally invasive technologies are expected to support increasing adoption of non-metallic stents.

End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Care Centers (ACS) (Fastest-Growing Segment)

The hospitals end-use segment accounted for a 71.14% share of the stents market in 2026, supported by the concentration of complex interventional procedures, specialized cardiovascular services, advanced imaging capabilities, and multidisciplinary clinical expertise in hospital settings. Stent implantation frequently requires specialized facilities and trained healthcare professionals capable of managing diagnostic evaluation, device placement, and potential procedural complications. Hospitals also provide access to comprehensive perioperative and post-procedure care, making them important centers for a broad range of stent-based interventions. The availability of advanced infrastructure and specialist services continues to reinforce the dominant role of hospitals in stent utilization.

The ambulatory care centers end-use segment is expected to register the fastest growth as improvements in minimally invasive procedures and patient management increasingly enable selected interventions to be performed outside traditional hospital settings. Ambulatory centers can provide streamlined procedural environments, shorter patient stays, and potentially greater convenience for appropriate patients undergoing less complex interventions. Advances in procedural techniques, imaging, device delivery systems, and post-procedure monitoring are expanding the range of treatments that can be considered in outpatient-oriented settings. As healthcare systems place greater emphasis on efficient care delivery and reducing unnecessary inpatient utilization, ambulatory care centers are expected to gain increasing importance in stent-related procedures.